Big Gain For NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ) rocketted at $5.47, a gain of 67.3%. On Thu, Feb 01, 2024, NRBO:NASDAQ touched a New 2-Week High of $5.47. The stock appeared on our News Catalysts scanner on Thu, Feb 01, 2024 at 10:57 AM in the 'BIOTECH' category. From Thu, Jan 18, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days

About NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ)

NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Its product candidate comprises NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy; NB-02, which treat the symptoms of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid-beta plaque deposition; Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia.